Candriam SCA’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20M | Buy |
693,869
+204,958
| +42% | +$5.89M | 0.12% | 165 |
|
2025
Q1 | $16.4M | Buy |
+488,911
| New | +$16.4M | 0.1% | 181 |
|
2024
Q2 | – | Sell |
-88,005
| Closed | -$4.12M | – | 697 |
|
2024
Q1 | $4.12M | Sell |
88,005
-200,006
| -69% | -$9.36M | 0.03% | 375 |
|
2023
Q4 | $10.2M | Buy |
+288,011
| New | +$10.2M | 0.07% | 245 |
|